市場調查報告書

長片段定序的全球市場 - 產業趨勢和2027年為止的預測

Global Long Read Sequencing Market - Industry Trends and Forecast to 2027

出版商 Data Bridge Market Research Private Limited 商品編碼 928641
出版日期 內容資訊 英文 337 Pages
商品交期: 最快1-2個工作天內
價格
長片段定序的全球市場 - 產業趨勢和2027年為止的預測 Global Long Read Sequencing Market - Industry Trends and Forecast to 2027
出版日期: 2020年06月01日內容資訊: 英文 337 Pages
簡介

全球長片段定序市場,在2020年∼2027年的在預測期間內,預計以健全的年複合成長率成長。

本報告提供全球長片段定序市場相關調查分析,市場概要,各市場區隔的市場分析,各地區的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 簡介

第2章 市場區隔

第3章 摘要整理

第4章 重要考察

第5章 市場概要

  • 促進因素
  • 阻礙因素
  • 機會
  • 課題

第6章 全球長片段定序市場:各技術

  • 概要
  • 單分子即時定序
  • 奈米孔洞定序
  • 合成長片段定序
  • 其他

第7章 全球長片段定序市場:各產品

  • 概要
  • 消耗品
    • 套件
    • 探針
    • 其他
  • 服務
    • 定序
    • 分析
    • 程序庫調整
    • 其他
  • 計量儀器
    • 獨立
    • 可攜式

第8章 全球長片段定序市場:各用途

  • 概要
  • 全基因測序
  • 目標定序
  • 表觀遺傳學
  • RNA定序
  • 複雜的人口
  • 其他

第9章 全球長片段定序市場:各工作流程

  • 概要
  • 定序
  • 資料分析
  • 預定序

第10章 全球長片段定序市場:各終端用戶

  • 概要
  • 學術、研究機關
  • 製藥、生物科技企業
  • 臨床檢驗室
  • 醫院、診所
  • 其他

第11章 全球長片段定序市場:各流通管道

  • 概要
  • 直接競標
  • 零售

第12章 全球長片段定序市場:各地區

  • 概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 荷蘭
    • 瑞士
    • 比利時
    • 土耳其
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 日本
    • 澳洲
    • 韓國
    • 新加坡
    • 印度
    • 馬來西亞
    • 泰國
    • 印尼
    • 菲律賓
    • 其他的亞太地區
  • 南美
    • 巴西
    • 阿根廷
    • 其他南美
  • 中東、非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 以色列
    • 埃及
    • 其他中東、非洲

第13章 全球長片段定序市場:企業形勢

  • 企業佔有率分析:世界
  • 企業佔有率分析:北美
  • 企業佔有率分析:歐洲
  • 企業佔有率分析:亞太地區

第14章 SWOT分析與Data Bridge Market Research分析

  • SWOT分析
  • Data Bridge Market Research分析

第15章 企業簡介

  • ILLUMINA, INC.
  • THERMO FISHER SCIENTIFIC INC.
  • OXFORD NANOPORE TECHNOLOGIES
  • PERKINELMER INC.
  • NOVOGENE CORPORATION
  • PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
  • AGILENT TECHNOLOGIES, INC.
  • BASECLEAR B.V.
  • BGI
  • BIOCAT GMBH
  • FG TECHNOLOGIES
  • GENEWIZ INC.
  • LEXOGEN GMBH
  • LONGAS TECHNOLOGIES
  • LOOP GENOMICS
  • MACROGEN, INC.
  • PROMEGA CORPORATION
  • QIAGEN
  • QUANTAPORE, INC.
  • ROCHE SEQUENCING
  • TAKARA BIO INC.
  • TATAA BIOCENTER
  • UNIVERSAL SEQUENCING TECHNOLOGY (UST)

第16章 問卷調查

第17章 結論

第18章 相關報告

目錄

Global long read sequencing market is projected to register a healthy CAGR in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

Global Long Read Sequencing Market, By Technology (Single- Molecule Real- Time Sequencing, Nanopore Sequencing, Synthetic Long Read Sequencing and Others), Product (Instruments, Consumables and Services), Application (Whole Genome Sequencing, Epigenetics, RNA Sequencing, Complex Population, Targeted Sequencing and Others), Workflow (Pre-Sequencing, Sequencing and Data Analysis), End-user (Academic & Research Institutes, Clinical Laboratories, Hospitals, Pharma & Biotech Entities and Others), Distribution Channel (Direct Tender and Retail Sales), Country (U.S., Canada and Mexico, Germany, United Kingdom, Italy, France, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, and rest of Europe, Japan, China, India, South Korea, Australia, Thailand, Malaysia, Singapore, Philippines, Indonesia and rest of Asia-Pacific, Brazil, Argentina and rest of South America, South Africa, UAE, Israel, Saudi Arabia, Egypt and rest of Middle East & Africa) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the global long read sequencing market are:

Rising prevalence of genetic disorders

Increased R&D expenditure

Market Players:

The key market players for global long read sequencing market are listed below:

Illumina, Inc.

Oxford Nanopore Technologies

PerkinElmerInc.

Thermo Fisher Scientific, Inc.

Novogene Corporation

Macrogen, Inc.

BaseClear B.V.

GENEWIZ Inc. (A subsidiary of Brooks Automation, Inc.)

Pacific Biosciences of California, Inc.

Takara Bio Inc.

TATAA Biocenter

FG Technologies

Roche Sequencing (A subsidiary of F. Hoffmann-La Roche Ltd)

Universal Sequencing Technology (UST)

QIAGEN

BioCat GmbH

LOOP GENOMICS

BGI

Lexogen GmbH

Promega Corporation

Agilent Technologies, Inc

Longas Technologies

Quantapore, Inc.

TABLE OF CONTENTS

1 INTRODUCTION 36

  • 1.1 OBJECTIVES OF THE STUDY 36
  • 1.2 MARKET DEFINITION 36
  • 1.3 OVERVIEW OF GLOBAL LONG READ SEQUENCING MARKET 40
  • 1.4 LIMITATIONS 41
  • 1.5 MARKETS COVERED 42

2 MARKET SEGMENTATION 44

  • 2.1 MARKETS COVERED 44
  • 2.2 GEOGRAPHICAL SCOPE 45
  • 2.3 YEARS CONSIDERED FOR THE STUDY 46
  • 2.4 CURRENCY AND PRICING 46
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 47
  • 2.6 MULTIVARIATE MODELLING 50
  • 2.7 PRODUCTS LIFELINE CURVE 50
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 51
  • 2.9 DBMR MARKET POSITION GRID 52
  • 2.10 VENDOR SHARE ANALYSIS 53
  • 2.11 APPLICATION GROD 54
  • 2.12 SECONDARY SOURCES 55
  • 2.13 ASSUMPTIONS 55

3 EXECUTIVE SUMMARY 56

4 PREMIUM INSIGHTS 60

5 MARKET OVERVIEW 62

  • 5.1 DRIVERS 64
    • 5.1.1 ADVANCEMENT IN THIRD-GENERATION LONG-READ SEQUENCING TECHNIQUES 64
    • 5.1.2 INCREASED R&D EXPENDITURE 65
    • 5.1.3 INCREASING APPLICATION IN CLINICAL SEQUENCING & ANALYSIS 66
    • 5.1.4 RISING PREVALENCE OF GENETIC DISORDERS 67
  • 5.2 RESTRAINTS 69
    • 5.2.1 HIGH COST OF THE LONG READ SEQUENCING PROCEDURE 69
    • 5.2.2 TECHNOLOGICAL CHALLENGES OF PROCESS 70
  • 5.3 OPPORTUNITIES 71
    • 5.3.1 RISING ADVANTAGES OF LONG READ SEQUENCING 71
    • 5.3.2 POTENTIAL TO OVERCOME SPECIFIC LIMITATIONS ASSOCIATED WITH NEXT-GENERATION SEQUENCING-BASED INVESTIGATIONS OF CLINICAL DISORDERS 72
  • 5.4 CHALLENGES 73
    • 5.4.1 INCREASED ERROR RATES 73
    • 5.4.2 SCALABILITY OF LONG READ DATA 73

6 GLOBAL LONG READ SEQUENCING MARKET, BY TECHNOLOGY 74

  • 6.1 OVERVIEW 75
  • 6.2 SINGLE-MOLECULE REAL-TIME SEQUENCING 78
  • 6.3 NANOPORE SEQUENCING 78
  • 6.4 SYNTHETIC LONG READ SEQUENCING 79
  • 6.5 OTHERS 79

7 GLOBAL LONG READ SEQUENCING MARKET, BY PRODUCT 80

  • 7.1 OVERVIEW 81
  • 7.2 CONSUMABLES 84
    • 7.2.1 KITS 85
      • 7.2.1.1 LIGATION SEQUENCING KIT 85
      • 7.2.1.2 PCR SEQUENCING KIT 85
      • 7.2.1.3 RAPID PCR SEQUENCING KIT 85
      • 7.2.1.4 RAPID / FIELD SEQUENCING KIT 85
      • 7.2.1.5 DIRECT RNA SEQUENCING KIT 85
      • 7.2.1.6 DIRECT CDNA SEQUENCING KIT 86
      • 7.2.1.7 16S BARCODING KIT 86
      • 7.2.1.8 OTHERS 86
    • 7.2.2 PROBES 86
    • 7.2.3 OTHERS 86
  • 7.3 SERVICES 86
    • 7.3.1 SEQUENCING 87
    • 7.3.2 ANALYSIS 87
    • 7.3.3 LIBRARY PREPARATION 87
    • 7.3.4 OTHERS 87
  • 7.4 INSTRUMENTS 87
    • 7.4.1 STANDALONE 88
    • 7.4.2 PORTABLE 88

8 GLOBAL LONG READ SEQUENCING MARKET, BY APPLICATION 89

  • 8.1 OVERVIEW 90
  • 8.2 WHOLE GENOME SEQUENCING 93
    • 8.2.1 HUMAN WHOLE GENOME 93
    • 8.2.2 MICROBIAL WHOLE GENOME 93
    • 8.2.3 OTHERS 93

  • 8.3 TARGETED SEQUENCING 94
    • 8.3.1 MICROBIOLOGY AND INFECTIOUS DISEASE RESEARCH 94
    • 8.3.2 HUMAN BIOMEDICAL RESEARCH 94
    • 8.3.3 HLA SEQUENCING 95
    • 8.3.4 OTHERS 95
  • 8.4 EPIGENETICS 95
  • 8.5 RNA SEQUENCING 95
  • 8.6 COMPLEX POPULATION 96
  • 8.7 OTHERS 96

9 GLOBAL LONG READ SEQUENCING MARKET, BY WORKFLOW 97

  • 9.1 OVERVIEW 98
  • 9.2 SEQUENCING 101
  • 9.3 DATA ANALYSIS 101
  • 9.4 PRE- SEQUENCING 102

10 GLOBAL LONG READ SEQUENCING MARKET, BY END USER 103

  • 10.1 OVERVIEW 104
  • 10.2 ACADEMIC & RESEARCH INSTITUTES 107
  • 10.3 PHARMA & BIOTECH ENTITIES 108
  • 10.4 CLINICAL LABORATORIES 108
  • 10.5 HOSPITALS & CLINICS 109
  • 10.6 OTHERS 109

11 GLOBAL LONG READ SEQUENCING MARKET, BY DISTRIBUTION CHANNEL 110

  • 11.1 OVERVIEW 111
  • 11.2 DIRECT TENDER 114
  • 11.3 RETAIL SALES 114

12 GLOBAL LONG READ SEQUENCING MARKET, BY GEOGRAPHY 115

  • 12.1 OVERVIEW 116
  • 12.2 NORTH AMERICA 121
    • 12.2.1 U.S. 128
    • 12.2.2 CANADA 132
    • 12.2.3 MEXICO 136
  • 12.3 EUROPE 140
    • 12.3.1 GERMANY 147
    • 12.3.2 FRANCE 151
    • 12.3.3 ITALY 155
    • 12.3.4 U.K. 159
    • 12.3.5 SPAIN 163
    • 12.3.6 RUSSIA 167
    • 12.3.7 NETHERLANDS 171
    • 12.3.8 SWITZERLAND 175
    • 12.3.9 BELGIUM 179
    • 12.3.10 TURKEY 183
    • 12.3.11 REST OF EUROPE 187
  • 12.4 ASIA-PACIFIC 188
    • 12.4.1 CHINA 195
    • 12.4.2 JAPAN 199
    • 12.4.3 AUSTRALIA 203
    • 12.4.4 SOUTH KOREA 207
    • 12.4.5 SINGAPORE 211
    • 12.4.6 INDIA 215
    • 12.4.7 MALAYSIA 219
    • 12.4.8 THAILAND 223
    • 12.4.9 INDONESIA 227
    • 12.4.10 PHILIPPINES 231
    • 12.4.11 REST OF ASIA-PACIFIC 235
  • 12.5 SOUTH AMERICA 236
    • 12.5.1 BRAZIL 243
    • 12.5.2 ARGENTINA 247
    • 12.5.3 REST OF SOUTH AMERICA 251
  • 12.6 MIDDLE EAST AND AFRICA 252
    • 12.6.1 SAUDI ARABIA 259
    • 12.6.2 SOUTH AFRICA 263
    • 12.6.3 U.A.E. 267
    • 12.6.4 ISRAEL 271
    • 12.6.5 EGYPT 275
    • 12.6.6 REST OF MIDDLE EAST & AFRICA 279

13 GLOBAL LONG READ SEQUENCING MARKET, COMPANY LANDSCAPE 280

  • 13.1 COMPANY SHARE ANALYSIS: GLOBAL 280
  • 13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 281
  • 13.3 COMPANY SHARE ANALYSIS: EUROPE 282
  • 13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 283

14 SWOT ANALYSIS AND DATA BRIDGE MARKET RESEARCH ANALYSIS 284

  • 14.1 SWOT ANALYSIS 284
    • 14.1.1 STRENGTH: - STRONG GLOBAL PRESENCE 284
    • 14.1.2 WEAKNESS: - WEAK PRODUCT PORTFOLIO 284
    • 14.1.3 OPPORTUNITY: - BUSINESS EXPANSION THROUGH SUBSIDIARIES 285
    • 14.1.4 THREAT: - FLUCTUATIONS IN CURRENCY CONVERSION 286
  • 14.2 DATA BRIDGE MARKET RESEARCH ANALYSIS 286

15 COMPANY PROFILE 287

  • 15.1 ILLUMINA, INC. 287
    • 15.1.1 COMPANY SNAPSHOT 287
    • 15.1.2 REVENUE ANALYSIS 288
    • 15.1.3 COMPANY SHARE ANALYSIS 288
    • 15.1.4 PRODUCT PORTFOLIO 289
    • 15.1.5 RECENT DEVELOPMENTS 290
  • 15.2 THERMO FISHER SCIENTIFIC INC. 291
    • 15.2.1 COMPANY SNAPSHOT 291
    • 15.2.2 REVENUE ANALYSIS 292
    • 15.2.3 COMPANY SHARE ANALYSIS 292
    • 15.2.4 PRODUCT PORTFOLIO 293
    • 15.2.5 RECENT DEVELOPMENT 293
  • 15.3 OXFORD NANOPORE TECHNOLOGIES 294
    • 15.3.1 COMPANY SNAPSHOT 294
    • 15.3.2 COMPANY SHARE ANALYSIS 294
    • 15.3.3 PRODUCT PORTFOLIO 295
    • 15.3.4 RECENT DEVELOPMENTS 295
  • 15.4 PERKINELMER INC. 296
    • 15.4.1 COMPANY SNAPSHOT 296
    • 15.4.2 REVENUE ANALYSIS 297
    • 15.4.3 COMPANY SHARE ANALYSIS 297
    • 15.4.4 SERVICE PORTFOLIO 298
    • 15.4.5 RECENT DEVELOPMENT 298
  • 15.5 NOVOGENE CORPORATION 299
    • 15.5.1 REVENUE ANALYSIS 299
    • 15.5.2 COMPANY SHARE ANALYSIS 299
    • 15.5.3 SERVICE PORTFOLIO 300
    • 15.5.4 RECENT DEVELOPMENTS 300
  • 15.6 PACIFIC BIOSCIENCES OF CALIFORNIA, INC. 301
    • 15.6.1 COMPANY SNAPSHOT 301
    • 15.6.2 REVENUE ANALYSIS 302
    • 15.6.3 PRODUCT PORTFOLIO 303
    • 15.6.4 RECENT DEVELOPMENTS 304

  • 15.7 AGILENT TECHNOLOGIES, INC. 305
    • 15.7.1 COMPANY SNAPSHOT 305
    • 15.7.2 REVENUE ANALYSIS 306
    • 15.7.3 PRODUCT PORTFOLIO 306
    • 15.7.4 RECENT DEVELOPMENT 307
  • 15.8 BASECLEAR B.V. 308
    • 15.8.1 COMPANY SNAPSHOT 308
    • 15.8.2 PRODUCT PORTFOLIO 308
    • 15.8.3 SERVICE PORTFOLIO 308
    • 15.8.4 RECENT DEVELOPMENTS 309
  • 15.9 BGI 310
    • 15.9.1 COMPANY SNAPSHOT 310
    • 15.9.2 PRODUCT PORTFOLIO 310
    • 15.9.3 RECENT DEVELOPMENTS 311
  • 15.10 BIOCAT GMBH 312
    • 15.10.1 COMPANY SNAPSHOT 312
    • 15.10.2 PRODUCT PORTFOLIO 312
    • 15.10.3 RECENT DEVELOPMENT 312
  • 15.11 FG TECHNOLOGIES 313
    • 15.11.1 COMPANY SNAPSHOT 313
    • 15.11.2 SOLUTION PORTFOLIO 313
    • 15.11.3 RECENT DEVELOPMENT 313
  • 15.12 GENEWIZ INC. (A SUBSIDIARY OF BROOKS AUTOMATION, INC.) 314
    • 15.12.1 COMPANY SNAPSHOT 314
    • 15.12.2 REVENUE ANALYSIS 314
    • 15.12.3 SERVICE PORTFOLIO 315
    • 15.12.4 RECENT DEVELOPMENTS 315
  • 15.13 LEXOGEN GMBH 316
    • 15.13.1 COMPANY SNAPSHOT 316
    • 15.13.2 PRODUCT PORTFOLIO 316
    • 15.13.3 RECENT DEVELOPMENT 316
  • 15.14 LONGAS TECHNOLOGIES 317
    • 15.14.1 COMPANY SNAPSHOT 317
    • 15.14.2 TECHNOLOGY PORTFOLIO 317
    • 15.14.3 RECENT DEVELOPMENT 317
  • 15.15 LOOP GENOMICS 318
    • 15.15.1 COMPANY SNAPSHOT 318
    • 15.15.2 PRODUCT PORTFOLIO 318
    • 15.15.3 SERVICE PORTFOLIO 318
    • 15.15.4 RECENT DEVELOPMENTS 319
  • 15.16 MACROGEN, INC. 320
    • 15.16.1 COMPANY SNAPSHOT 320
    • 15.16.2 REVENUE ANALYSIS 320
    • 15.16.3 SERVICE PORTFOLIO 321
    • 15.16.4 RECENT DEVELOPMENT 321
  • 15.17 PROMEGA CORPORATION 322
    • 15.17.1 COMPANY SNAPSHOT 322
    • 15.17.2 PRODUCT PORTFOLIO 322
    • 15.17.3 RECENT DEVELOPMENT 322
  • 15.18 QIAGEN 323
    • 15.18.1 COMPANY SNAPSHOT 323
    • 15.18.2 REVENUE ANALYSIS 324
    • 15.18.3 PRODUCT PORTFOLIO 324
    • 15.18.4 RECENT DEVELOPMENTS 325
  • 15.19 QUANTAPORE, INC. 326
    • 15.19.1 COMPANY SNAPSHOT 326
    • 15.19.2 TECHNOLOGY PORTFOLIO 326
    • 15.19.3 RECENT DEVELOPMENT 326
  • 15.20 ROCHE SEQUENCING ( A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD) 327
    • 15.20.1 COMPANY SNAPSHOT 327
    • 15.20.2 REVENUE ANALYSIS 327
    • 15.20.3 PRODUCT PORTFOLIO 328
    • 15.20.4 RECENT DEVELOPMENT 328
  • 15.21 TAKARA BIO INC. 329
    • 15.21.1 COMPANY SNAPSHOT 329
    • 15.21.2 REVENUE ANALYSIS 330
    • 15.21.3 PRODUCT PORTFOLIO 330
    • 15.21.4 RECENT DEVELOPMENT 330
  • 15.22 TATAA BIOCENTER 331
    • 15.22.1 COMPANY SNAPSHOT 331
    • 15.22.2 SERVICE PORTFOLIO 331
    • 15.22.3 RECENT DEVELOPMENT 331
  • 15.23 UNIVERSAL SEQUENCING TECHNOLOGY (UST) 332
    • 15.23.1 COMPANY SNAPSHOT 332
    • 15.23.2 PRODUCT PORTFOLIO 332
    • 15.23.3 RECENT DEVELOPMENT 332

16 QUESTIONNAIRE 333

17 CONCLUSION 336

18 RELATED REPORTS 337

LIST OF FIGURES

LIST OF FIGURES

  • FIGURE 1 GLOBAL LONG READ SEQUENCING MARKET: SEGMENTATION 44
  • FIGURE 2 GLOBAL LONG READ SEQUENCING MARKET: DATA TRIANGULATION 47
  • FIGURE 3 GLOBAL LONG READ SEQUENCING MARKET: DROC ANALYSIS 48
  • FIGURE 4 GLOBAL LONG READ SEQUENCING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 49
  • FIGURE 5 GLOBAL LONG READ SEQUENCING MARKET: COMPANY RESEARCH ANALYSIS 49
  • FIGURE 6 GLOBAL LONG READ SEQUENCING MARKET: INTERVIEW DEMOGRAPHICS 51
  • FIGURE 2 GLOBAL LONG READ SEQUENCING MARKET: VENDOR SHARE ANALYSIS 53
  • FIGURE 3 GLOBAL LONG READ SEQUENCING MARKET: APPLICATION GRID 54
  • FIGURE 4 GLOBAL LONG READ SEQUENCING MARKET: SEGMENTATION 58
  • FIGURE 5 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL LONG READ SEQUENCING MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2020 TO 2027 59
  • FIGURE 6 INCREASING APPLICATION IN CLINICAL SEQUENCING & ANALYSIS AND RISING PREVALENCE OF GENETIC DISORDERS ARE DRIVING THE GLOBAL LONG READ SEQUENCING MARKET IN THE FORECAST PERIOD 2020 TO 2027 60
  • FIGURE 7 SINGLE- MOLECULE REAL- TIME SEQUENCING IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL LONG READ SEQUENCING MARKET IN 2020 & 2027 60
  • FIGURE 8 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR LONG READ SEQUENCING MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027 61
  • FIGURE 9 DRIVERS, RESTRAINTS, OPPORTUNITIES & CHALLENGES OF GLOBAL LONG READ SEQUENCING MARKET 63
  • FIGURE 10 GENDER WISE PREVALENCE OF CYSTIC FIBROSIS 67
  • FIGURE 11 GLOBAL LONG READ SEQUENCING MARKET: BY TECHNOLOGY, 2019 75
  • FIGURE 12 GLOBAL LONG READ SEQUENCING MARKET: BY TECHNOLOGY, 2019-2027 (USD MILLION) 76
  • FIGURE 13 GLOBAL LONG READ SEQUENCING MARKET: BY TECHNOLOGY, CAGR (2020-2027) 76
  • FIGURE 14 GLOBAL LONG READ SEQUENCING MARKET: BY TECHNOLOGY, LIFELINE CURVE 77
  • FIGURE 15 GLOBAL LONG READ SEQUENCING MARKET: BY PRODUCT, 2019 81
  • FIGURE 16 GLOBAL LONG READ SEQUENCING MARKET: BY PRODUCT, 2019-2027 (USD MILLION) 82
  • FIGURE 17 GLOBAL LONG READ SEQUENCING MARKET: BY PRODUCT, CAGR (2020-2027) 82
  • FIGURE 18 GLOBAL LONG READ SEQUENCING MARKET: BY PRODUCT, LIFELINE CURVE 83
  • FIGURE 19 GLOBAL LONG READ SEQUENCING MARKET: BY APPLICATION, 2019 90
  • FIGURE 20 GLOBAL LONG READ SEQUENCING MARKET: BY APPLICATION, 2019-2027 (USD MILLION) 91
  • FIGURE 21 GLOBAL LONG READ SEQUENCING MARKET: BY APPLICATION, CAGR (2020-2027) 91
  • FIGURE 22 GLOBAL LONG READ SEQUENCING MARKET: BY APPLICATION, LIFELINE CURVE 92
  • FIGURE 23 GLOBAL LONG READ SEQUENCING MARKET: BY WORKFLOW, 2019 98
  • FIGURE 24 GLOBAL LONG READ SEQUENCING MARKET, BY WORKFLOW, 2019-2027 (USD MILLION) 99
  • FIGURE 25 GLOBAL LONG READ SEQUENCING MARKET: BY WORKFLOW, CAGR (2020-2027) 99
  • FIGURE 26 GLOBAL LONG READ SEQUENCING MARKET: BY WORKFLOW, LIFELINE CURVE 100
  • FIGURE 27 GLOBAL LONG READ SEQUENCING MARKET: BY END USER, 2019 104
  • FIGURE 28 GLOBAL LONG READ SEQUENCING MARKET: BY END USER, 2019-2027 (USD MILLION) 105
  • FIGURE 29 GLOBAL LONG READ SEQUENCING MARKET: BY END USER, CAGR (2020-2027) 105
  • FIGURE 30 GLOBAL LONG READ SEQUENCING MARKET: BY END USER, LIFELINE CURVE 106
  • FIGURE 31 GLOBAL LONG READ SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2019 111
  • FIGURE 32 GLOBAL LONG READ SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION) 112
  • FIGURE 33 GLOBAL LONG READ SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027) 112
  • FIGURE 34 GLOBAL LONG READ SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 113
  • FIGURE 35 GLOBAL LONG READ SEQUENCING MARKET: SNAPSHOT (2019) 117
  • FIGURE 36 GLOBAL LONG READ SEQUENCING MARKET: BY REGION (2019) 118
  • FIGURE 37 GLOBAL LONG READ SEQUENCING MARKET: BY REGION (2020 & 2027) 118
  • FIGURE 38 GLOBAL LONG READ SEQUENCING MARKET: BY REGION (2019 & 2027) 119
  • FIGURE 39 GLOBAL LONG READ SEQUENCING MARKET: BY TECHNOLOGY (2020-2027) 119
  • FIGURE 40 NORTH AMERICA LONG READ SEQUENCING MARKET: SNAPSHOT (2019) 121
  • FIGURE 41 NORTH AMERICA LONG READ SEQUENCING MARKET: BY COUNTRY (2019) 122
  • FIGURE 42 NORTH AMERICA LONG READ SEQUENCING MARKET: BY COUNTRY (2020 & 2027) 122
  • FIGURE 43 NORTH AMERICA LONG READ SEQUENCING MARKET: BY COUNTRY (2019 & 2027) 123
  • FIGURE 44 NORTH AMERICA LONG READ SEQUENCING MARKET: BY TECHNOLOGY (2020-2027) 123
  • FIGURE 45 EUROPE LONG READ SEQUENCING MARKET: SNAPSHOT (2019) 140
  • FIGURE 46 EUROPE LONG READ SEQUENCING MARKET: BY COUNTRY (2019) 141
  • FIGURE 47 EUROPE LONG READ SEQUENCING MARKET: BY COUNTRY (2020 & 2027) 141
  • FIGURE 48 EUROPE LONG READ SEQUENCING MARKET: BY COUNTRY (2019 & 2027) 142
  • FIGURE 49 EUROPE LONG READ SEQUENCING MARKET: BY TECHNOLOGY (2020-2027) 142
  • FIGURE 50 ASIA-PACIFIC LONG READ SEQUENCING MARKET: SNAPSHOT (2019) 188
  • FIGURE 51 ASIA-PACIFIC LONG READ SEQUENCING MARKET: BY COUNTRY (2019) 189
  • FIGURE 52 ASIA-PACIFIC LONG READ SEQUENCING MARKET: BY COUNTRY (2020 & 2027) 189
  • FIGURE 53 ASIA-PACIFIC LONG READ SEQUENCING MARKET: BY COUNTRY (2019 & 2027) 190
  • FIGURE 54 ASIA-PACIFIC LONG READ SEQUENCING MARKET: BY TECHNOLOGY (2020-2027) 190
  • FIGURE 55 SOUTH AMERICA LONG READ SEQUENCING MARKET: SNAPSHOT (2019) 236
  • FIGURE 56 SOUTH AMERICA LONG READ SEQUENCING MARKET: BY COUNTRY (2019) 237
  • FIGURE 57 SOUTH AMERICA LONG READ SEQUENCING MARKET: BY COUNTRY (2020 & 2027) 237
  • FIGURE 58 SOUTH AMERICA LONG READ SEQUENCING MARKET: BY COUNTRY (2019 & 2027) 238
  • FIGURE 59 SOUTH AMERICA LONG READ SEQUENCING MARKET: BY TECHNOLOGY (2020-2027) 238
  • FIGURE 60 MIDDLE EAST AND AFRICA LONG READ SEQUENCING MARKET: SNAPSHOT (2019) 252
  • FIGURE 61 MIDDLE EAST AND AFRICA LONG READ SEQUENCING MARKET: BY COUNTRY (2019) 253
  • FIGURE 62 MIDDLE EAST AND AFRICA LONG READ SEQUENCING MARKET: BY COUNTRY (2020 & 2027) 253
  • FIGURE 63 MIDDLE EAST AND AFRICA LONG READ SEQUENCING MARKET: BY COUNTRY (2019 & 2027) 254
  • FIGURE 64 MIDDLE EAST AND AFRICA LONG READ SEQUENCING MARKET: BY TECHNOLOGY (2020-2027) 254
  • FIGURE 65 GLOBAL LONG READ SEQUENCING MARKET: COMPANY SHARE 2019 (%) 280
  • FIGURE 66 NORTH AMERICA LONG READ SEQUENCING MARKET: COMPANY SHARE 2019 (%) 281
  • FIGURE 67 EUROPE LONG READ SEQUENCING MARKET: COMPANY SHARE 2019 (%) 282
  • FIGURE 68 ASIA-PACIFIC LONG READ SEQUENCING MARKET: COMPANY SHARE 2019 (%) 283